透析环境中丙型肝炎病毒的传播及其预防策略。
Transmission of hepatitis C virus in the dialysis setting and strategies for its prevention.
作者信息
Nguyen Duc B, Bixler Danae, Patel Priti R
机构信息
Centers for Diseases Control and Prevention, Atlanta, Georgia.
出版信息
Semin Dial. 2019 Mar;32(2):127-134. doi: 10.1111/sdi.12761. Epub 2018 Dec 19.
Abstract
Hepatitis C virus (HCV) infection is more common among hemodialysis patients than the general population and transmission of HCV in dialysis clinics has been reported. In the context of the increased morbidity and mortality associated with HCV infection in the end stage renal disease population, it is important that dialysis clinics have processes in place for ensuring recommended infection control practices, including Standard Precautions, through regular audits and training of the staff. This review will summarize the epidemiology of HCV infection and risk factors for HCV transmission among hemodialysis patients. In addition, the proper protocols are required to investigate suspected cases of HCV transmission in dialysis facilities and recommendations for prevention of HCV transmission in will be reviewed.
摘要
丙型肝炎病毒（HCV）感染在血液透析患者中比普通人群更为常见，并且已有报道称HCV在透析诊所中传播。鉴于终末期肾病患者中与HCV感染相关的发病率和死亡率不断上升，透析诊所通过定期审计和对工作人员进行培训来制定确保推荐的感染控制措施（包括标准预防措施）的流程非常重要。本综述将总结HCV感染的流行病学以及血液透析患者中HCV传播的危险因素。此外，还将审查调查透析设施中疑似HCV传播病例的适当方案以及预防HCV传播的建议。
相似文献
1
Transmission of hepatitis C virus in the dialysis setting and strategies for its prevention.透析环境中丙型肝炎病毒的传播及其预防策略。
Semin Dial. 2019 Mar;32(2):127-134. doi: 10.1111/sdi.12761. Epub 2018 Dec 19.
2
Hepatitis C virus in chronic dialysis patients.慢性透析患者中的丙型肝炎病毒
Minerva Urol Nefrol. 2005 Sep;57(3):175-97.
3
Prevention of hepatitis B virus and hepatitis C virus transmission in hemodialysis centers: review of current international recommendations.血液透析中心乙型肝炎病毒和丙型肝炎病毒传播的预防：当前国际建议综述
Arab J Nephrol Transplant. 2011 Jan;4(1):35-47. doi: 10.4314/ajnt.v4i1.63154.
4
A 1990s perspective of hepatitis C, human immunodeficiency virus, and tuberculosis infections in dialysis patients.20世纪90年代对透析患者丙型肝炎、人类免疫缺陷病毒和结核感染的看法。
Semin Nephrol. 1997 Jul;17(4):346-63.
5
Hepatitis C virus screening and management of seroconversions in hemodialysis facilities.血液透析机构中丙型肝炎病毒筛查及血清转化的管理
Semin Dial. 2013 Jul-Aug;26(4):439-46. doi: 10.1111/sdi.12097. Epub 2013 May 31.
6
Epidemiology, surveillance, and prevention of hepatitis C virus infections in hemodialysis patients.血液透析患者丙型肝炎病毒感染的流行病学、监测和预防。
Am J Kidney Dis. 2010 Aug;56(2):371-8. doi: 10.1053/j.ajkd.2010.01.025. Epub 2010 Jun 8.
8
The impact of nurse understaffing on the transmission of hepatitis C virus in a hospital-based hemodialysis unit.医院血液透析科室护士配备不足对丙型肝炎病毒传播的影响。
Med Princ Pract. 2004 May-Jun;13(3):129-35. doi: 10.1159/000076951.
9
Hepatitis C virus transmission in hemodialysis units: importance of infection control practices and aseptic technique.血液透析单位中的丙型肝炎病毒传播：感染控制措施和无菌技术的重要性。
Infect Control Hosp Epidemiol. 2009 Sep;30(9):900-3. doi: 10.1086/605472.
10
Transmission of hepatitis C virus infection in hemodialysis: current concepts.血液透析中丙型肝炎病毒感染的传播：当前概念
Int J Artif Organs. 2008 Dec;31(12):1004-16. doi: 10.1177/039139880803101204.
引用本文的文献
1
Hepatitis C virus among hemodialysis patients: burden, risks, and prevention in resource-limited regions.血液透析患者中的丙型肝炎病毒：资源有限地区的负担、风险及预防
Int Urol Nephrol. 2025 May 7. doi: 10.1007/s11255-025-04555-6.
2
Hepatitis C Virus Seroprevalence and Genotypic Distribution Among Hemodialysis Patients at a Teaching and Training Hospital in Western Rajasthan, India.印度拉贾斯坦邦西部一家教学与培训医院血液透析患者中丙型肝炎病毒血清流行率及基因分型分布
Cureus. 2024 Aug 19;16(8):e67175. doi: 10.7759/cureus.67175. eCollection 2024 Aug.
3
The efficacy and safety of direct-acting antiviral regimens for end-stage renal disease patients with HCV infection: a systematic review and network meta-analysis.直接作用抗病毒方案治疗 HCV 感染终末期肾病患者的疗效和安全性：系统评价和网络荟萃分析。
Front Public Health. 2023 Sep 29;11:1179531. doi: 10.3389/fpubh.2023.1179531. eCollection 2023.
4
The Seroprevalence of Hepatitis C Virus (HCV) in Hemodialysis Patients in Oman: A National Cross-Sectional Study.阿曼血液透析患者丙型肝炎病毒（HCV）的血清流行率：一项全国性横断面研究。
J Epidemiol Glob Health. 2023 Dec;13(4):774-781. doi: 10.1007/s44197-023-00149-6. Epub 2023 Sep 12.
5
Prevalence and Genotypes of Hepatitis C Infection Among Hemodialysis Patients in Bushehr, Iran.伊朗布什尔血液透析患者丙型肝炎感染的患病率及基因型
Oman Med J. 2023 Mar 31;38(2):e481. doi: 10.5001/omj.2023.60. eCollection 2023 Mar.
6
Hepatitis C Seroconversion Remains High among Patients with Regular Hemodialysis: Study of Associated Risk Factors.定期血液透析患者丙型肝炎血清学转换率仍然很高：相关危险因素研究
Int J Hepatol. 2022 Dec 29;2022:8109977. doi: 10.1155/2022/8109977. eCollection 2022.
7
Molecular characterization and genotyping of hepatitis C virus from Sudanese end-stage renal disease patients on haemodialysis.苏丹血液透析终末期肾病患者丙型肝炎病毒的分子特征和基因分型。
BMC Infect Dis. 2022 Nov 14;22(1):848. doi: 10.1186/s12879-022-07833-1.
8
Epidemiology of haemodialysis outcomes.血液透析结局的流行病学。
Nat Rev Nephrol. 2022 Jun;18(6):378-395. doi: 10.1038/s41581-022-00542-7. Epub 2022 Feb 22.
9
Prevalence and genotype distribution of hepatitis C virus within hemodialysis units in Thailand: role of HCV core antigen in the assessment of viremia.泰国血液透析中心丙型肝炎病毒的流行情况和基因型分布：丙型肝炎病毒核心抗原在评估病毒血症中的作用。
BMC Infect Dis. 2022 Jan 22;22(1):79. doi: 10.1186/s12879-022-07074-2.
10
Management of hepatitis B and C in special population.特殊人群的乙型肝炎和丙型肝炎管理。
World J Gastroenterol. 2021 Oct 28;27(40):6861-6873. doi: 10.3748/wjg.v27.i40.6861.
本文引用的文献
1
Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014.2004 年至 2014 年美国与阿片类药物流行及相关注射吸毒相关的急性丙型肝炎病毒感染增加。
Am J Public Health. 2018 Feb;108(2):175-181. doi: 10.2105/AJPH.2017.304132. Epub 2017 Dec 21.
2
GHOST: global hepatitis outbreak and surveillance technology.GHOST：全球肝炎爆发和监测技术。
BMC Genomics. 2017 Dec 6;18(Suppl 10):916. doi: 10.1186/s12864-017-4268-3.
3
Race, Age, and Geography Impact Hepatitis C Genotype Distribution in the United States.种族、年龄和地理位置影响美国丙型肝炎基因型分布。
J Clin Gastroenterol. 2019 Jan;53(1):40-50. doi: 10.1097/MCG.0000000000000872.
4
Treating Hepatitis C in Patients with Renal Failure.治疗肾衰竭患者的丙型肝炎。
Dig Dis. 2017;35(4):339-346. doi: 10.1159/000456585. Epub 2017 May 3.
5
Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010.2010年美国各州及哥伦比亚特区丙型肝炎病毒感染的州级患病率估计
Clin Infect Dis. 2017 Jun 1;64(11):1573-1581. doi: 10.1093/cid/cix202.
6
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.2015 年全球丙型肝炎病毒感染的流行率和基因型分布：一项建模研究。
Lancet Gastroenterol Hepatol. 2017 Mar;2(3):161-176. doi: 10.1016/S2468-1253(16)30181-9. Epub 2016 Dec 16.
7
Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study.丙型肝炎病毒载量、基因型与终末期肾病发病风险增加：REVEAL-HCV 研究。
Hepatology. 2017 Sep;66(3):784-793. doi: 10.1002/hep.29192. Epub 2017 Jul 18.
8
Prevalence of false-positive hepatitis C antibody results, National Health and Nutrition Examination Study (NHANES) 2007-2012.2007 - 2012年美国国家健康与营养检查调查（NHANES）中丙型肝炎抗体假阳性结果的患病率
J Clin Virol. 2017 Apr;89:1-4. doi: 10.1016/j.jcv.2017.01.007. Epub 2017 Jan 30.
9
Mortality, Hospitalization, and Quality of Life among Patients with Hepatitis C Infection on Hemodialysis.血液透析患者丙型肝炎感染的死亡率、住院率和生活质量。
Clin J Am Soc Nephrol. 2017 Feb 7;12(2):287-297. doi: 10.2215/CJN.07940716. Epub 2016 Dec 1.
10
Isolation as a strategy for controlling the transmission of hepatitis C virus (HCV) infection in haemodialysis units.隔离作为血液透析单位控制丙型肝炎病毒（HCV）感染传播的一种策略。
Cochrane Database Syst Rev. 2016 Aug 11;2016(8):CD006420. doi: 10.1002/14651858.CD006420.pub2.
Zotero 插件